uric acid has been researched along with osteoprotegerin in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 1 (50.00) | 2.80 |
Authors | Studies |
---|---|
Abd El Wahab, AM; El-Azab, GA; Elshahawy, H; Mostafa, TM; Sayed-Ahmed, NA; Zakaria, H | 1 |
Erazmus, M; Kucharska, AM; Majcher, A; Pyrżak, B; Rumińska, M; Stelmaszczyk-Emmel, A; Witkowska-Sędek, E | 1 |
1 trial(s) available for uric acid and osteoprotegerin
Article | Year |
---|---|
The impact of fish oil and wheat germ oil combination on mineral-bone and inflammatory markers in maintenance hemodialysis patients: a randomized, double-blind, placebo-controlled clinical trial.
Topics: Adult; Alkaline Phosphatase; Antioxidants; Biomarkers; C-Reactive Protein; Calcium; Dietary Supplements; Double-Blind Method; Drug Therapy, Combination; Fatty Acids, Omega-3; Female; Ferritins; Fish Oils; Hemoglobins; Humans; Kidney Failure, Chronic; Leukocyte Count; Male; Middle Aged; Osteoprotegerin; Parathyroid Hormone; Phosphorus; Plant Oils; Prospective Studies; Renal Dialysis; Uric Acid | 2017 |
1 other study(ies) available for uric acid and osteoprotegerin
Article | Year |
---|---|
Decreased level of soluble receptor activator of nuclear factor-κβ ligand (sRANKL) in overweight and obese children.
Topics: Adolescent; Child; Humans; Ligands; Osteogenesis; Osteoprotegerin; Overweight; Pediatric Obesity; RANK Ligand; Uric Acid | 2022 |